Wednesday, 15 May 2013

Lucentis

Lucentis

Lucentis
Generic name/Active ingredient: Ranibizumab 10 mg/ ml (Intravitreal)
Trade name: Lucentis
Dosage form: Injection
Drug classification: Monoclonal antibody
Legal classification: POM
Company: Novartis
Commonly used for: Age-related macular degeneration (AMD)